Amyris successfully advances strategic transaction

Emeryville, calif., dec. 27, 2022 /prnewswire/ -- amyris, inc. (nasdaq: amrs), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its lab-to-markettm technology platform today announced that it has completed the negotiation of key financial and business terms of the previously communicated strategic transaction for the exclusive rights to supply two of amyris' ingredients.
AMRS Ratings Summary
AMRS Quant Ranking